CELCUITY INC. Interest Expense Nonoperating
CELCUITY INC. (CELC) reported Interest Expense Nonoperating of $5.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- CELCUITY INC. interest expense nonoperating for the quarter ending 2026-06-30 was $5.42M, a 69.26% increase year-over-year.
- CELCUITY INC. interest expense nonoperating for the quarter ending 2026-03-31 was $6.08M, a 91.17% increase year-over-year.
- CELCUITY INC. interest expense nonoperating for the quarter ending 2025-12-31 was $6.17M, a 88.27% increase year-over-year.
- CELCUITY INC. interest expense nonoperating for the quarter ending 2025-09-30 was $4.59M, a 37.41% increase year-over-year.
- CELCUITY INC. interest expense nonoperating for fiscal 2025 was $17.15M, a 66.81% increase from fiscal 2024.
- CELCUITY INC. interest expense nonoperating for fiscal 2024 was $10.28M, a 93.00% increase from fiscal 2023.
- CELCUITY INC. interest expense nonoperating for fiscal 2023 was $5.33M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month | Interest Expense Nonoperating 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $5.42M 10-Q · filed 2026-08-13 | $11.51M 10-Q · filed 2026-08-13 | $17.67M derived: sum of 3 quarters · filed 2026-08-13 | $22.27M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $6.08M 10-Q · filed 2026-05-14 | $12.25M derived: sum of 2 quarters · filed 2026-05-14 | $16.85M derived: sum of 3 quarters · filed 2026-05-14 | $20.05M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $10.76M derived: sum of 2 quarters · filed 2026-03-26 | $13.96M derived: sum of 3 quarters · filed 2026-08-13 | $17.15M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $4.59M 10-Q · filed 2025-11-13 | $7.80M derived: sum of 2 quarters · filed 2026-08-13 | $10.98M 10-Q · filed 2025-11-13 | $14.26M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $3.20M 10-Q · filed 2026-08-13 | $6.39M 10-Q · filed 2026-08-13 | $9.66M derived: sum of 3 quarters · filed 2026-08-13 | $13.01M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $3.18M 10-Q · filed 2026-05-14 | $6.46M derived: sum of 2 quarters · filed 2026-05-14 | $9.80M derived: sum of 3 quarters · filed 2026-05-14 | $12.06M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $6.62M derived: sum of 2 quarters · filed 2026-03-26 | $8.88M derived: sum of 3 quarters · filed 2026-03-26 | $10.28M 10-K · filed 2026-03-26 | $10.28M 10-K · filed 2025-03-31 |
| 2024-09-30 | $3.34M 10-Q · filed 2025-11-13 | $5.60M derived: sum of 2 quarters · filed 2025-11-13 | $7.00M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $2.26M 10-Q · filed 2025-08-14 | $3.66M 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $1.40M 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $5.33M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |